Verified Supplement Data Primary-sourced

Creatine for Women: Same 3–5 g, Different Evidence Base

By Erin Rose · Published · Reviewed against primary sources · Methodology · About Us

Informational summary of the ISSN position stand and published trials, not medical advice. If you are pregnant, breastfeeding, have kidney disease or take an antidepressant, the clinician managing your care has the final say on any supplement.

Quick answer

A woman does not need a different creatine, a different form or a different dose. It is the same molecule at the same 3–5 g of creatine monohydrate a day, and the trials in women used plain monohydrate. What the studies looked at: strength in women who lift, a small lean-mass difference that was smaller than in men, and bone measures after menopause. There are no human trials in pregnancy.

Products sold for women often list a smaller dose per serving. We read 1,200 creatine labels filed with the NIH: monohydrate labels sit at a median 5 g per serving, the studied dose, while creatine HCl sits at 2 g and buffered creatine at 1.5 g. Those labels list less than the 3–5 g used in the trials. See the census →

Maintenance dose · ISSN3–5g / day, any sex
Separate women’s doseNonein any guideline or trial
HCl labels, median dose 2 g vs 5 g monohydrate · 1,200 labels

Already sold on monohydrate? See the best creatine picks ranked by cost per 5 g →

On this page
  1. Dose by goal
  2. The evidence in women
  3. Water, bulk, hair, kidneys
  4. What the shelf sells
  5. Which to buy
  6. FAQ

The dose table for women, by goal

The International Society of Sports Nutrition position stand puts the maintenance dose at 3–5 g of creatine monohydrate a day, with an optional loading week, and carries no footnote for sex (Kreider 2017, PMID: 28615996). The trials in women mostly dosed by body weight, which lands in the same range for a 55–70 kg woman and a little above it in the postmenopausal bone studies. The table gives the practical dose beside what each trial used.

Creatine for women by goal: the practical daily dose, what the trials in women used, and what they found. All doses are creatine monohydrate.
GoalPractical doseWhat the trials in women usedWhat they found
General health, not training3 g/day3 g/day for 2 years, 200 postmenopausal women with osteopenia, no exercise program (Sales 2020)The authors reported no change in bone density, lean mass or muscle function.
Resistance training, premenopausal3–5 g/day; loading optional0.5 g per kg of fat-free mass for 5 days, 22 college-age women (Kambis 2003) · 20 g/day loading, 39 active women (Gordon 2023)Quadriceps power measures changed in five days; no change in body weight or thigh circumference. Sprint fatigue results varied by cycle phase.
Resistance training, after menopause5 g/day, with the training0.1 g/kg/day for 12 months (Chilibeck 2015) · 0.14 g/kg/day for 2 years, 237 women (Chilibeck 2023)Femoral-neck bone loss differed at 12 months; at 2 years there was no density difference, with some differences in femoral geometry, walking time and lean mass in completers.
Strength and lean mass, 60+5 g/day, with the trainingPooled trials, 608 postmenopausal women (Naddafha 2026); 24 weeks, 60 vulnerable older women (Gualano 2014)+0.37 kg lean mass and +7.5 kg leg press with creatine at 5 g or more plus training; 3 g or less without training showed no measurable difference.

Loading, timing, cycling and the body-weight calculator are on the creatine dosage guide. Nothing there changes for women.

What the evidence specifically in women says

Most creatine trials enrolled men, and most of what you read about creatine and women is extrapolated. The 2021 lifespan review put the gap plainly: women are understudied, the review reports women’s endogenous creatine stores as 70–80% lower than men’s, and hormonal shifts across the cycle, pregnancy and menopause change creatine kinetics in ways that have barely been tested (Smith-Ryan 2021, PMID: 33800439). The 2025 follow-up reaches the same place: early trials ignored the menstrual cycle, the strength and body-composition benefits hold when creatine is paired with resistance training, and the pregnancy and perimenopause data remain thin (Smith-Ryan 2025, PMID: 40371844). Both reviews list authors who advise a creatine manufacturer, and so do the ISSN position stand, the 2026 menopause meta-analysis and the animal-pregnancy review cited on this page; the primary trials cited here (Kambis, Chilibeck, Sales, Korovljev) are the ones to weigh. Below is what the primary trials show.

Muscle and strength: the lean-mass difference was smaller than in men

In 22 college-age women, five days of creatine loading was followed by shorter time to peak quadriceps torque and higher average power in extension and flexion, with no change in fat-free mass, body fat, thigh circumference or body weight (Kambis 2003, PMID: 12660408).

The lean-mass effect is where honesty matters. A meta-analysis of 35 randomized trials and 1,192 participants found creatine raised lean body mass by 0.68 kg overall and by 1.10 kg when combined with resistance training. Split by sex, men gained 1.46 kg and women a non-significant 0.29 kg (Delpino 2022, PMID: 35986981). In these trials creatine was paired with training, and the lean-mass difference in women was small.

In older women the strength signal is clearer than the mass signal. Ten randomized trials in 211 older females reported higher upper-body strength with creatine plus resistance training, with lower-body strength differences in trials of at least 24 weeks and no difference in muscle mass (Dos Santos 2021, PMID: 34836013). In 60 vulnerable older women, the creatine-plus-training group scored highest on bench press and appendicular lean mass; the creatine-only group did not (Gualano 2014, PMID: 24530883). Creatine was studied alongside training, not in place of it.

Bone after menopause: what the trials measured

The trials are listed in order. A 12-month trial randomized 47 postmenopausal women to 0.1 g/kg/day of creatine or placebo during supervised resistance training. Femoral-neck bone density fell 1.2% on creatine against 3.9% on placebo, and the femoral shaft was wider; 33 women finished (Chilibeck 2015, PMID: 25386713). The same group then ran a longer trial: 237 postmenopausal women, 0.14 g/kg/day, resistance training three days a week plus walking six, for two years. The authors reported no difference in bone mineral density at the femoral neck, hip or spine. They did report differences in two femoral-neck geometry measures, 80 m walking time, and lean mass in completers (Chilibeck 2023, PMID: 37144634).

Without the training, the results differed. Two hundred postmenopausal women with osteopenia took 3 g/day of creatine or placebo for two years with no exercise program: bone density, microarchitecture, bone markers, falls, fractures, lean mass and muscle function were all unchanged, and the authors concluded that creatine alone did not change these measures (Sales 2020, PMID: 31257405). The 2026 meta-analysis of seven trials and 608 postmenopausal women pooled them: lean mass +0.37 kg and leg press +7.5 kg when creatine at 5 g/day or more was combined with resistance training; 3 g/day or less without training showed no measurable difference; bone density unchanged; adverse events were reported as mild and similar to placebo (Naddafha 2026, PMID: 42141930). Ask your clinician about bone health.

Cognition: early and mixed results

Creatine has been studied for memory and thinking. One small trial enrolled 45 young vegetarians who took 5 g/day for six weeks in a crossover design and were tested on backward digit span and Raven’s matrices (Rae 2003, PMID: 14561278). A meta-analysis of randomized trials in healthy people reported differences on some memory measures, mostly in older adults (Prokopidis 2023, PMID: 35984306). A separate systematic review called the cognitive results equivocal (McMorris 2024, PMID: 38582412). This page does not claim creatine improves memory or thinking.

Perimenopause and menopause: very little research

The bone and muscle data above are most of the research in this life stage. One small randomized trial gave 36 perimenopausal and menopausal women eight weeks of creatine HCl at 750 mg/day, HCl at 1,500 mg/day, HCl plus creatine ethyl ester at 800 mg/day, or placebo, about nine women per arm. The 1,500 mg HCl group differed from placebo on reaction time and frontal brain creatine, and mood-swing severity did not reach significance (Korovljev 2026, PMID: 40854087). It is a small pilot. This page does not claim creatine helps any menopause symptom; ask your clinician.

Pregnancy: no human trial, and this page will not pretend otherwise

Animal models of maternal supplementation have been studied (Muccini 2021, PMID: 33540766). A Cochrane review set out to pool randomized trials of creatine in pregnant women and found none, completed or ongoing (Dickinson 2014, PMID: 25523279). The 2025 expert review on creatine misconceptions still lists creatine use during pregnancy as an open question (Antonio 2025, PMID: 39720835). No dose is given here, and the same applies to breastfeeding, where no controlled trial exists at all. The clinician managing your pregnancy decides.

The menstrual cycle: one trial, one phase, one qualified result

Cycle-timed creatine has a single study behind it. Thirty-nine active women loaded 20 g/day of monohydrate or placebo and repeated sprint testing in the low-hormone and high-hormone phases. There was a phase-by-supplement interaction for fatigue index, with the largest change in the high-hormone phase on creatine, and the authors describe creatine’s ability to counteract the luteal performance dip as not statistically significant (Gordon 2023, PMID: 37630756). Take it daily; saturation is cumulative and the cycle is not.

Water, bulk, hair and kidneys: what the data say

Water. Creatine is osmotically active and pulls water into the muscle cell. The expert review on misconceptions finds the effect short-term, tied to loading, and not supported as long-term water retention at the 3–5 g/day recommended dose (Antonio 2021, PMID: 33557850). In the five-day loading study in women, body weight did not move (Kambis 2003).

Bulk. The 0.29 kg non-significant lean-mass gain in women across 35 trials (Delpino 2022) is the answer. Creatine adds reps, and the tissue that follows is whatever your training and diet build. In these trials the lean-mass difference in women was not statistically significant.

Hair. The worry traces to one 2009 study in which 20 male rugby players loading 25 g/day showed a rise in DHT within the normal range (van der Merwe 2009, PMID: 19741313). The first trial to measure hair directly randomized 45 resistance-trained men to 5 g/day or placebo for 12 weeks and found no difference in DHT, other hormones, hair density, follicular count or hair thickness (Lak 2025, PMID: 40265319). Both studies are in men; no trial has measured hair in women, and no trial in women has reported an androgenic signal. Creatine is not a hormone.

Kidneys. Creatine raises serum creatinine because creatinine is what creatine turns into, and a creatinine reading is how kidney function is usually estimated. A meta-analysis of 12 studies found a small rise in serum creatinine with supplementation and no significant change in glomerular filtration rate, the measure that reflects kidney function (Naeini 2025, PMID: 41199218). In the 12-month postmenopausal trial, creatinine clearance stayed normal throughout (Chilibeck 2015). Tell whoever orders your bloodwork that you take creatine, so a raised creatinine is read correctly. If you have kidney disease, the ISSN safety data do not cover you; that decision belongs to your nephrologist.

We read 1,200 creatine labels: the women’s shelf sells a smaller dose, not a different one

Original research Every on-market creatine supplement label filed with the NIH Dietary Supplement Label Database (2,412 on the market, 1,200 read, 969 with a parseable creatine quantity, 788 with a daily direction), with the grams per serving taken from the Supplement Facts panel and the declared chemical form from the ingredient line.

Some creatine products are sold for women in other forms at a smaller dose. The labels show the smaller dose. Creatine monohydrate labels sit at a median 5 g per serving, and the 90th percentile is 5 g: the form barely varies, and it varies around the studied dose (599 labels). Creatine HCl sits at a median 2 g (110 labels), buffered creatine at 1.5 g (43), magnesium creatine chelate at 0.6 g (39), and labels that name no form at 3 g (171). Each of those median label doses is below the 3–5 g used in the trials.

Median creatine per serving, by declared form
0 g 1.5 g 3 g 4.5 g 6 g Creatine monohydrate 599 labels 5 g No form named 171 labels 3 g Creatine HCl 110 labels 2 g Buffered / Kre-Alkalyn 43 labels 1.5 g Magnesium chelate 39 labels 0.6 g
Monohydrate labels sit at a median 5 g per serving, the studied dose. HCl sits at 2 g, buffered creatine at 1.5 g and magnesium chelate at 0.6 g, all below the 3–5 g/day the evidence supports. Source: Our census of 969 DSLD creatine labels with a parseable quantity, 2026-08-30.
Median creatine per serving, by declared form
ItemValue ( g)
Creatine monohydrate5 g
No form named3 g
Creatine HCl2 g
Buffered / Kre-Alkalyn1.5 g
Magnesium chelate0.6 g

Two more things the labels show. First, the day’s dose runs a little above the scoop: the median label directs 3.5 g per day against a median 3 g per serving, because a share of labels direct more than one serving. Second, the census has no women’s split: the NIH database does not tag a label by intended sex and we did not build a subset by brand name, so the figures above are shelf-wide and no separate women’s population was censused. Gummies barely appear in the NIH database at all, so this read cannot measure the gummy shelf; the creatine gummies guide handles it product by product.

Method: 1,200 labels retrieved from the NIH Dietary Supplement Label Database (DSLD) v9 on 2026-08-30 for the term “creatine” (2,412 on the market); 969 declare creatine with a parseable quantity and 788 carry a daily direction. Grams per serving is the panel quantity for the labeled serving; grams per day multiplies it by the maximum daily servings directed. Form is the declared chemical form in the ingredient line. Medians are stated against labels that declared a quantity, never against labels read. What it cannot tell you: which products sell most, whether a scoop holds what the panel says, which labels are marketed to women, or anything about products not filed with the NIH.

The product links below go to Amazon and we may earn a commission if you buy. It never changes which product we pick or what we say about it. How we choose.

For most women: Optimum Nutrition Micronized Creatine Monohydrate (60 servings) $0.30/day is plain micronized monohydrate at 5 g a scoop, and the value pick on our best creatine ranking. Take 3–5 g a day and skip the loading week unless you have a deadline.

If you want an NSF-registry tub: Thorne Creatine (90 servings) $0.49/day is micronized creatine monohydrate. This exact product is confirmed in the NSF registry (NSF/ANSI 173). Same molecule, same dose.

On a budget: NOW Sports Creatine Monohydrate Powder (600g) $0.19/day is the same monohydrate for less. Whatever you choose, compare the grams of creatine per serving on the label.

Check price →

Frequently asked questions

Does creatine make women gain weight?

A small amount, early, and it is water inside the muscle rather than fat. A five-day loading study in 22 college-age women found no change in body weight, fat-free mass, body fat or thigh circumference. Across 35 trials, women on creatine gained a non-significant 0.29 kg of lean mass against 1.46 kg in men. If the scale moves in week one it is intramuscular water.

Does creatine cause bloating in women?

Loading doses (20 g a day split into four) can cause stomach upset and a short-term rise in body water. A steady 3–5 g a day does neither in most people, and the expert review on creatine misconceptions finds no evidence of long-term water retention at the recommended dose. If you are prone to bloating, skip loading and take one 3–5 g dose with a meal.

Should women do a loading phase?

Only if you have a deadline. Loading (about 20 g a day for 5–7 days) saturates muscle in roughly a week; 3–5 g a day reaches the same place in three to four weeks. The trials in women used both routes. Loading is where the early water weight and stomach complaints come from, so the steady dose is the better default.

Can I take creatine while breastfeeding?

There is no controlled trial of creatine supplementation in breastfeeding women, so no one can call it safe or unsafe from data. Ask the clinician managing your care.

Can I take creatine while pregnant?

No human trial has tested it. A Cochrane review looking for randomized trials of creatine in pregnancy found none, and the 2025 expert review on creatine misconceptions still lists pregnancy safety as an open question. Animal data are not an answer for people. This page makes no recommendation for pregnancy.

Is there a best time in my cycle to take creatine?

The evidence is a single 39-woman trial. Sprint fatigue results differed by cycle phase, and the authors describe the effect on the luteal dip as not statistically significant. Take creatine every day and ignore the cycle.

Do I need a women's creatine, a gummy or creatine HCl?

No. There is no women's molecule. Creatine monohydrate is the form every trial in women used, and it is sold at a median 5 g per serving on the labels we read. Creatine HCl labels sit at a median 2 g and buffered creatine at 1.5 g, below the 3–5 g the evidence supports for any form. Gummies barely appear in the NIH label database at all. Buy plain monohydrate and check the grams.

Does creatine affect women's hormones or cause hair loss?

Creatine is not a hormone. The hair-loss worry comes from one 2009 study of 20 male rugby players whose DHT rose during loading; a 2025 randomized trial of 45 men found no change in DHT, other hormones or measured hair density after 12 weeks at 5 g a day. Neither study included women, no trial has measured hair in women, and no trial has shown an androgenic effect at any dose studied.

Related guides

Sources

  1. Kreider RB, et al. "International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine." J Int Soc Sports Nutr. 2017;14:18. PMID: 28615996
  2. Smith-Ryan AE, et al. "Creatine Supplementation in Women's Health: A Lifespan Perspective." Nutrients. 2021;13(3):877. PMID: 33800439
  3. Smith-Ryan AE, et al. "Creatine in women's health: bridging the gap from menstruation through pregnancy to menopause." J Int Soc Sports Nutr. 2025;22(1):2502094. PMID: 40371844
  4. Kambis KW, Pizzedaz SK. "Short-term creatine supplementation improves maximum quadriceps contraction in women." Int J Sport Nutr Exerc Metab. 2003;13(1):87-96. PMID: 12660408
  5. Delpino FM, et al. "Influence of age, sex, and type of exercise on the efficacy of creatine supplementation on lean body mass: A systematic review and meta-analysis of randomized clinical trials." Nutrition. 2022;103-104:111791. PMID: 35986981
  6. Dos Santos EEP, et al. "Efficacy of Creatine Supplementation Combined with Resistance Training on Muscle Strength and Muscle Mass in Older Females: A Systematic Review and Meta-Analysis." Nutrients. 2021;13(11):3757. PMID: 34836013
  7. Gualano B, et al. "Creatine supplementation and resistance training in vulnerable older women: a randomized double-blind placebo-controlled clinical trial." Exp Gerontol. 2014;53:7-15. PMID: 24530883
  8. Chilibeck PD, et al. "Effects of Creatine and Resistance Training on Bone Health in Postmenopausal Women." Med Sci Sports Exerc. 2015;47(8):1587-95. PMID: 25386713
  9. Chilibeck PD, et al. "A 2-yr Randomized Controlled Trial on Creatine Supplementation during Exercise for Postmenopausal Bone Health." Med Sci Sports Exerc. 2023;55(10):1750-1760. PMID: 37144634
  10. Sales LP, et al. "Creatine Supplementation (3 g/d) and Bone Health in Older Women: A 2-Year, Randomized, Placebo-Controlled Trial." J Gerontol A Biol Sci Med Sci. 2020;75(5):931-938. PMID: 31257405
  11. Naddafha S, et al. "Creatine monohydrate for lean mass, strength, and bone density in postmenopausal women: a systematic review and meta-analysis." J Int Soc Sports Nutr. 2026;23(1):2668435. PMID: 42141930
  12. Rae C, et al. "Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial." Proc Biol Sci. 2003;270(1529):2147-50. PMID: 14561278
  13. Prokopidis K, et al. "Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials." Nutr Rev. 2023;81(4):416-427. PMID: 35984306
  14. McMorris T, et al. "Creatine supplementation research fails to support the theoretical basis for an effect on cognition: Evidence from a systematic review." Behav Brain Res. 2024;466:114982. PMID: 38582412
  15. Korovljev D, et al. "The Effects of 8-Week Creatine Hydrochloride and Creatine Ethyl Ester Supplementation on Cognition, Clinical Outcomes, and Brain Creatine Levels in Perimenopausal and Menopausal Women (CONCRET-MENOPA): A Randomized Controlled Trial." J Am Nutr Assoc. 2026;45(3):199-210. PMID: 40854087
  16. Muccini AM, et al. "Creatine Metabolism in Female Reproduction, Pregnancy and Newborn Health." Nutrients. 2021;13(2):490. PMID: 33540766
  17. Dickinson H, et al. "Creatine for women in pregnancy for neuroprotection of the fetus." Cochrane Database Syst Rev. 2014;(12):CD010846. PMID: 25523279
  18. Antonio J, et al. "Part II. Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show?" J Int Soc Sports Nutr. 2025;22(1):2441760. PMID: 39720835
  19. Gordon AN, et al. "The Effects of Creatine Monohydrate Loading on Exercise Recovery in Active Women throughout the Menstrual Cycle." Nutrients. 2023;15(16):3567. PMID: 37630756
  20. Antonio J, et al. "Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show?" J Int Soc Sports Nutr. 2021;18(1):13. PMID: 33557850
  21. van der Merwe J, et al. "Three weeks of creatine monohydrate supplementation affects … in college-aged rugby players." Clin J Sport Med. 2009;19(5):399-404. PMID: 19741313
  22. Lak M, et al. "Does creatine cause hair loss? A 12-week randomized controlled trial." J Int Soc Sports Nutr. 2025;22(sup1):2495229. PMID: 40265319
  23. Naeini EK, et al. "Effect of creatine supplementation on kidney function: a systematic review and meta-analysis." BMC Nephrol. 2025;26(1):622. PMID: 41199218
  24. NIH Office of Dietary Supplements. Dietary Supplement Label Database. dsld.od.nih.gov (creatine labels retrieved 2026-08-30).